1885-1948: Innovative beginnings 1885-1948: Innovative beginnings The Boehringer Ingelheim history from its start in 1885 to 1948, with milestones and important products
Boehringer Ingelheim and GST prepared bring innovation to equine market Boehringer Ingelheim and GST prepared bring innovation to equine market Boehringer Ingelheim and Global Stem Cell Technology are prepared to bring groundbreaking innovation to equine market
Uncommon_Mutations_Database Uncommon_Mutations_Database New database of published clinical outcomes from patients with uncommon EGFR mutations in advanced NSCLC treated with afatinib is available for global clinician use
Upstream and Downstream Processing | Bioxcellence | Boehringer Ingelheim Upstream and Downstream Processing | Bioxcellence | Boehringer Ingelheim Experience our exceptional expertise in upstream & downstream biopharmaceutical processing, utilizing mammalian cell cultures & microbial organisms.
SPEVIGO CHMP positive opinion new indications SPEVIGO CHMP positive opinion new indications CHMP adopts positive opinion recommending approval of new and expanded indications for SPEVIGO®
Animal Health partnering interests Animal Health partnering interests Animal Health partnering interests
Ethical Business Practices Ethical Business Practices Suppliers shall conduct their business in an ethical manner and act with integrity.
Supporting local communities by offsetting carbon emissions Supporting local communities by offsetting carbon emissions Boehringer Ingelheim partially offsets its carbon emissions by partnering with ClimateSeed
Our-position Our-position Potential access to selected medications for appropriate patients with serious, life-threatening diseases unable to participate in a clinical trial
Option to Acquire Trutino Biosciences Option to Acquire Trutino Biosciences Option to Acquire Trutino Biosciences
The impact of A Life in a Day of a patient The impact of A Life in a Day of a patient A Life in a Day disease simulations are opening our eyes to the patient experience, exposing a surprising knowledge gap and driving change.
Patient Organizations Patient Organizations Boehringer Ingelheim’s core principles and vision guide our work with patient organisations.
Reimagining digital healthcare worldwide Reimagining digital healthcare worldwide How does our digital lab BI X innovate in Ingelheim and Shanghai? Read about success stories based on different ideation processes